4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-004372
Options or other derivatives
- Chief Financial Officer acquired 1,915,056 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Wood Gavin Chief Financial Officer | 2023-01-17 | Grant or award · Option to purchase Ordinary Shares | +1,407,072 | 1,407,072 | D | ||
| Wood Gavin Chief Financial Officer | 2023-01-17 | Grant or award · Option to purchase Ordinary Shares | +314,256 | 314,256 | D | ||
| Wood Gavin Chief Financial Officer | 2023-01-17 | Grant or award · Option to purchase Ordinary Shares | +193,728 | 193,728 | D | ||
Loading xslF345X03/tm231655-12_4seq1.xml…